Company Financials

ACADIA Pharmaceuticals Inc. Financials

United States dollar

business ACADIA Pharmaceuticals Inc. Company Profile

Main Stock Listing

NASDAQ: ACAD

Market Capitalization $4.45 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 16.96
Forward PE 32.65
Price to Sales TTM $4.25
Price to Book MRQ $4.85
Enterprise to Revenue 3.49
Enterprise to EBITDA 33.71

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 24.94%
Operating Margin 12.83%
Return on Assets TTM 5.11%
Return on Equity TTM 34.95%

Income Statement

Revenue TTM $1,047,118,016
Revenue per Share TTM $6.25
Quarterly Revenue Growth 11.30%
Gross Profit TTM $617,766,016
EBITDA $108,458,000
Net Income to Common TTM $261,174,000
Diluted EPS TTM $1.55
Quarterly Earnings Growth YoY 119.10%

Balance Sheet

Total Cash MRQ $847,019,008
Total Cash per Share MRQ $5.01
Total Debt MRQ $
Total Debt to Equity MRQ 5.98
Current Ratio MRQ 3.02
Book Value per Share MRQ $5.42

Cash Flow

Operating Cash Flow TTM $198,948,000
Levered Free Cash Flow TTM $25,785,000

ACAD Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 169,146,043
Float Shares 125,346,808
Avg 10 Volume 1,289,790
Avg 30 Volume None
Shares Short 8,681,267
Short Ratio 5.91
Short % of Shares 8.03%
% Held by Insiders 0.54%
% Held by Institutions 101.58%

Stock Price Summary

Beta 0.67
Fifty Two Week Low $13.40
Fifty Two Week High $28.35
Fifty Two Week Change 33.59%
Day 50 MA $24.70
Day 200 MA $21.83

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date